First Financial Bank - Trust Division’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $398K | Buy |
+2,098
| New | +$395K | 0.03% | 167 |
|
|
2026
Q1 | – | Sell |
-2,118
| Closed | -$389K | – | 200 |
|
|
2025
Q4 | $389K | Buy |
2,118
+42
| +2% | +$7.37K | 0.03% | 163 |
|
|
2025
Q3 | $318K | Sell |
2,076
-3
| -0.1% | -$454 | 0.03% | 174 |
|
|
2025
Q2 | $290K | Buy |
2,079
+50
| +2% | +$7.01K | 0.03% | 180 |
|
|
2025
Q1 | $298K | Sell |
2,029
-21
| -1% | -$3.04K | 0.03% | 178 |
|
|
2024
Q4 | $269K | Hold |
2,050
| – | – | 0.03% | 189 |
|
|
2024
Q3 | $319K | Buy |
2,050
+21
| +1% | +$3.39K | 0.03% | 183 |
|
|
2024
Q2 | $316K | Hold |
2,029
| – | – | 0.03% | 176 |
|
|
2024
Q1 | $275K | Hold |
2,029
| – | – | 0.03% | 178 |
|
|
2023
Q4 | $273K | Hold |
2,029
| – | – | 0.03% | 175 |
|
|
2023
Q3 | $275K | Hold |
2,029
| – | – | 0.03% | 164 |
|
|
2023
Q2 | $290K | Hold |
2,029
| – | – | 0.03% | 167 |
|
|
2023
Q1 | $282K | Hold |
2,029
| – | – | 0.03% | 173 |
|
|
2022
Q4 | $275K | Sell |
2,029
-52
| -2% | -$6.52K | 0.03% | 180 |
|
|
2022
Q3 | $228K | Buy |
2,081
+52
| +3% | +$6.6K | 0.03% | 169 |
|
|
2022
Q2 | $268K | Hold |
2,029
| – | – | 0.03% | 156 |
|
|
2022
Q1 | $269K | Hold |
2,029
| – | – | 0.03% | 159 |
|
|
2021
Q4 | $236K | Hold |
2,029
| – | – | 0.02% | 170 |
|
|
2021
Q3 | $244K | Hold |
2,029
| – | – | 0.03% | 163 |
|
|
2021
Q2 | $243K | Sell |
2,029
-235
| -10% | -$25.8K | 0.03% | 169 |
|
|
2021
Q1 | $225K | Sell |
2,264
-350
| -13% | -$35.2K | 0.03% | 178 |
|
|
2020
Q4 | $261K | Buy |
2,614
+50
| +2% | +$5.3K | 0.03% | 166 |
|
|
2020
Q3 | $281K | Hold |
2,564
| – | – | 0.04% | 149 |
|
|
2020
Q2 | $271K | Buy |
2,564
+235
| +10% | +$24.3K | 0.04% | 149 |
|
|
2020
Q1 | $208K | Hold |
2,329
| – | – | 0.04% | 163 |
|
|
2019
Q4 | $232K | Sell |
2,329
-262
| -10% | -$24.7K | 0.03% | 174 |
|
|
2019
Q3 | $231K | Hold |
2,591
| – | – | 0.03% | 169 |
|
|
2019
Q2 | $214K | Hold |
2,591
| – | – | 0.03% | 175 |
|
|
2019
Q1 | $209K | Buy |
+2,591
| New | +$204K | 0.03% | 179 |
|
|
2017
Q2 | – | Sell |
-3,759
| Closed | -$234K | – | 186 |
|
|
2017
Q1 | $234K | Buy |
3,759
+25
| +0.7% | +$1.46K | 0.04% | 164 |
|
|
2016
Q4 | $204K | Hold |
3,734
| – | – | 0.04% | 171 |
|
|
2016
Q3 | $246K | Sell |
3,734
-160
| -4% | -$10.5K | 0.05% | 165 |
|
|
2016
Q2 | $235K | Buy |
3,894
+265
| +7% | +$15.4K | 0.05% | 170 |
|
|
2016
Q1 | $205K | Sell |
3,629
-351
| -9% | -$21.1K | 0.04% | 178 |
|
|
2015
Q4 | $271K | Sell |
3,980
-59
| -1% | -$3.87K | 0.06% | 161 |
|
|
2015
Q3 | $257K | Hold |
4,039
| – | – | 0.06% | 157 |
|
|
2015
Q2 | $257K | Sell |
4,039
-225
| -5% | -$15.4K | 0.06% | 156 |
|
|
2015
Q1 | $292K | Sell |
4,264
-260
| -6% | -$18.1K | 0.06% | 156 |
|
|
2014
Q4 | $319K | Sell |
4,524
-36
| -0.8% | -$2.58K | 0.06% | 152 |
|
|
2014
Q3 | $326K | Buy |
4,560
+11
| +0.2% | +$805 | 0.07% | 148 |
|
|
2014
Q2 | $338K | Sell |
4,549
-700
| -13% | -$50.6K | 0.07% | 146 |
|
|
2014
Q1 | $340K | Sell |
5,249
-1,035
| -16% | -$66.8K | 0.07% | 149 |
|
|
2013
Q4 | $373K | Hold |
6,284
| – | – | 0.07% | 150 |
|
|
2013
Q3 | $327K | Sell |
6,284
-685
| -10% | -$34.4K | 0.08% | 139 |
|
|
2013
Q2 | $329K | Buy |
+6,969
| New | +$355K | 0.08% | 139 |
|
Other funds holding AZN
RG
AAMU
AIM
AV
MIF
ZIC
AIM
First Financial Bank - Trust Division's AZN Position: Q2 2026 in Review
First Financial Bank - Trust Division opened a new position in AstraZeneca (AZN) in Q2 2026: 2,098 shares worth $398K. The stake represents 0.03% of the portfolio and ranks #167 among its holdings. This is a return to the name: First Financial Bank - Trust Division previously reported a position in AZN as recently as Q4 2025.
First Financial Bank - Trust Division first reported a position in AZN in Q2 2013 and has held it in 45 quarters since. 399 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- First Financial Bank - Trust Division held 2,098 shares of AstraZeneca worth $398K as of Q2 2026.
- AstraZeneca was a new First Financial Bank - Trust Division position in Q2 2026.
- AstraZeneca made up 0.03% of First Financial Bank - Trust Division's portfolio in Q2 2026, its #167 holding.
- First Financial Bank - Trust Division first reported a position in AstraZeneca in Q2 2013 and has held it in 45 quarters since.
- 399 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on First Financial Bank - Trust Division's 13F filing for Q2 2026, filed 1 Jul 2026.